ArticleBritish journal of cancer2016

FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.

L Marzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.